Global Companies Make Significant Advances in Cryptocurrency Adoption

Global companies have made notable progress in diversifying their financial strategies and adopting compliant custody solutions, according to ChainCatcher. Key developments include Acurx Pharmaceuticals' board approval of a $10 million Bitcoin purchase to hedge against inflation risks affecting long-term research funds. Enfusion has updated its financial guidelines to allocate 10% of its surplus cash into Bitcoin and Ethereum, aiming to enhance the risk-adjusted returns of its treasury. Nature's Miracle has initiated a $5 million Bitcoin strategic treasury plan, marking a significant step for agritech firms in accepting cryptocurrency as a reserve currency. Additionally, Bakkt's Q4 forecast indicates a 40% year-over-year increase in enterprise-level crypto asset custody, highlighting the growing reliance on compliant third-party custodians by non-native crypto companies entering the market.